Clinical Trial Update: A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456) [Phase 1, Phase 2]

View source ↗

Summary

Phase I/IIa trial update for AERAS-456 in HIV-negative adults with and without latent tuberculosis infection has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis
• Tuberculosis

Drugs mentioned

• AERAS-456

Snippet

Sponsor: Aeras | Conditions: Latent Tuberculosis Bacteriology and Histology Unknown, Latent Tuberculosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-12-19